In 2022, the Population Council acquired the International Partnership for Microbicides (IPM), a nonprofit organization that develops HIV prevention technologies. This collection contains publications and other materials produced by IPM from 2002 to 2022. For more recent resources, visit the Dapivirine Vaginal Ring (PrEP Ring) page.
Annual Reports
2004 IPM Annual Report—Developing HIV-Prevention Options for Women Worldwide, International Partnership for Microbicides
2005 IPM Annual Report—Developing HIV-Prevention Options for Women Worldwide, International Partnership for Microbicides
2006 IPM Annual Report—Advancing HIV Prevention Options for Women, International Partnership for Microbicides
2007 IPM Annual Report—Microbicides: Prevention Through Partnership, International Partnership for Microbicides
2008 IPM Annual Report—Progress on the Path to HIV Prevention, International Partnership for Microbicides
2009 IPM Annual Report—Microbicides: New Science, New Hope, International Partnership for Microbicides
2010 IPM Annual Report—Building on Breakthroughs, International Partnership for Microbicides
2011 IPM Annual Report—A Decade of Progress Advancing HIV Prevention for Women, International Partnership for Microbicides
2012 IPM Annual Report—From Science to Solutions: Developing New Health Technologies for Women, International Partnership for Microbicides
2013 IPM Annual Report—Responding to Women’s Needs: Developing HIV and Multipurpose Prevention Products, International Partnership for Microbicides
2014 IPM Annual Report—The Promise of Prevention for Women, International Partnership for Microbicides
2015 IPM Annual Report—New Hope for Women's HIV Prevention, International Partnership for Microbicides
2016 IPM Annual Report—Hope, Progress and the Power of Prevention, International Partnership for Microbicides
2017 IPM Annual Report—Women & HIV Prevention: Expanding the Options, Empowering Women, International Partnership for Microbicides
Articles (peer-reviewed)
Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development, Barbara Friedland, Holly Gundacker, Sharon Achilles, Beatrice A. Chen, Craig Hoesley, Barbra A. Richardson, Clifton W. Kelly, Jeanna Piper, Sherri Johnson, Brid Devlin, John Steytler, Kyle Kleinbeck, Bindi Dangi, Chantel Friend, Mei Song, Barbara Mensch, Ariane van der Straten, Cindy Jacobson, Craig W. Hendrix, Jill Brown, Diana Blithe, Sharon L. Hiller, and on behalf of the MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: A randomised, open-label, crossover trial, Gonasagrie Nair, Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne Akello, Rita Nakalega, et al., and John Steytler
Characterization of viruses in Phase 3 and Phase 3b trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine vaginal ring for human immunodeficiency virus type 1 infection risk reduction, John Steytler, Charles Craig, Elna van der Ryst, Ben Van Baelen, Jeremy Nuttall, Neliette van Niekerk, John Mellors, Urvi Parikh, and Carole Wallis
Clinical presentation, treatment response, and virology outcomes of women who seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM, John Steytler, Elna van der Ryst, Charles Craig, Ben Van Baelen, Jeremy Nuttall, Neliette van Niekerk, John Mellors, Urvi Parikh, and Carole Wallis
In vitro drug release, mechanical performance and stability testing of a custom silicone elastomer vaginal ring releasing dapivirine and levonorgestrel, Diarmaid J. Murphy, Yahya H. Dallal Bashi, Clare F. McCoy, Peter Boyd, Leeanne Brown, François Martin, Nicole McMullen, Kyle Kleinbeck, Bindi Dangi, Patrick Spence, Bashir Hansraj, Brid Devlin, and R. Karl Malcolm
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings, Sharon Achilles, Clifton W. Kelly, Craig Hoesley, Diana Blithe, Jill Brown, Barbra A. Richardson, Brid Devlin, Craig W. Hendrix, Samuel M. Poloyac, Mark A. Marzinke, Holly Gundacker, Devika Singh, Jeanna Piper, Sherri Johnson, John Steytler, Beatrice A. Chen, and on behalf of the MTN-030/IPM 041 and MTN-044/IPM 053/CCN019 Protocol Teams for the Microbicide Trials Network and the Contraceptive Clinical Trials Network
Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring, Joseph W. Romano, Bruce Variano, P. Coplan, J. Van Roey, K. Douville, Zeda Rosenberg, Marleen Temmerman, H. Verstraelen, L. Van Bortel, S. Weyers, and M. Mitchnick
Silicone elastomer formulations for improved performance of a multipurpose vaginal ring releasing dapivirine and levonorgestrel, Yahya H. Dallal Bashi, Diarmaid J. Murphy, Clare F. McCoy, Peter Boyd, Leeanne Brown, Matthew Kihara, François Martin, Nicole McMullen, Kyle Kleinbeck, Bindi Dangi, Patrick Spence, Bashir Hansraj, Brid Devlin, and R. Karl Malcolm
Transport and permeation properties of dapivirine: Understanding potential drug-drug interactions, Ruohui Zheng, Guru R. Valicherla, Junmei Zhang, Jeremy Nuttall, Peter Silvera, Leslie J. Marshall, Philip E. Empey, and Lisa C. Rohan
Use of simulated vaginal and menstrual fluids to model in vivo discolouration of silicone elastomer vaginal rings, Clare F. McCoy, Patrick Spence, Yahya H. Dallal Bashi, Diarmaid J. Murphy, Peter Boyd, Bindi Dangi, Tiffany Derrick, Brid Devlin, Kyle Kleinbeck, and R. Karl Malcolm
Audio/Video
A Long-Acting and Woman-Controlled HIV Prevention Option, International Partnership for Microbicides
HIV Prevention for Women: The Promise of the Ring, International Partnership for Microbicides
Microbicides: Developing New HIV Prevention Options for Women, International Partnership for Microbicides
Briefs
Paving the Path: Preparing for Microbicide Introduction—Report of a Qualitative Study in South Africa [Executive Summary], Julie Becker, Rasha Dabash, C. Elizabeth McGrory, Diane Cooper, Jane Harries, Margaret Hoffman, Jennifer Moodley, Phyllis Orner, and Hillary J. Bracken
Data Sets
A Randomized, Phase 1, Open-Label Study in Healthy HIV-Negative Women to Evaluate the Pharmacokinetics, Safety and Bleeding Patterns Associated with 90-Day Use of Matrix Vaginal Rings Containing 200 mg Dapivirine and 320 mg, Barbara Friedland and Holly Gundacker
MTN-030/IPM-041: A Phase 1, Randomized, Double-Blind Pharmacokinetic and Safety Study of Dapivirine/Levonorgestrel Vaginal Rings, Barbara Friedland and Holly Gundacker
Fact Sheets
After the Ring Study: DREAM, International Partnership for Microbicides
A healthy world starts with healthy women, International Partnership for Microbicides
A long-acting ring for women’s HIV prevention, International Partnership for Microbicides
A multipurpose prevention ring for women's sexual and reproductive health, International Partnership for Microbicides
IPM: Pioneering HIV prevention options for women, International Partnership for Microbicides
Maternal health and HIV/AIDS, International Partnership for Microbicides
Microbicide Overview, International Partnership for Microbicides
Microbicides: Woman-centered HIV prevention to help end AIDS by 2030, International Partnership for Microbicides
Why microbicides for women?, International Partnership for Microbicides
Women and HIV/AIDS, International Partnership for Microbicides
Women and the need for microbicides, International Partnership for Microbicides
Reports
HIV/AIDS and the Millennium Development Goals: Microbicides and the need for long-term prevention, International Partnership for Microbicides
Microbicides Access Forum 2008, International Partnership for Microbicides
Microbicides research: Hope for the future, benefits for today, International Partnership for Microbicides
New technologies for women's HIV prevention: The payoff for sustainable development, International Partnership for Microbicides
Paving the Path: Preparing for Microbicide Introduction—Report of a Qualitative Study in South Africa, Julie Becker, Rasha Dabash, C. Elizabeth McGrory, Diane Cooper, Jane Harries, Margaret Hoffman, Jennifer Moodley, Phyllis Orner, and Hillary J. Bracken
Planning for microbicide access in developing countries: Lessons from the introduction of contraceptive technologies, George F. Brown, Vimala Raghavendran, and Saul Walker
The use of antiretroviral drugs (ARVs) in microbicides and the potential for the development of drug-resistant strains of HIV, International Partnership for Microbicides